Market Tracker

05/24 5:16pm ET

Lannett Company Inc (NYSE:LCI)

23.10
Delayed Data
As of 4:02pm ET
 +0.78 / +3.49%
Today’s Change
16.91
Today|||52-Week Range
62.90
-42.42%
Year-to-Date
Strong On High Relative Volume: Lannett (LCI)
May 20 / TheStreet.com - Paid Partner Content
3 Healthcare Stocks Bears Are Wrong About
May 18 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close22.32
Today’s open22.50
Day’s range22.46 - 23.26
Volume666,353
Average volume (3 months)1,162,197
Market cap$820.2M
Dividend yield--
Data as of 4:02pm ET, 05/24/2016

Growth & Valuation

Earnings growth (last year)+149.38%
Earnings growth (this year)-17.43%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+48.60%
P/E ratio11.5
Price/Sales5.42
Price/Book1.75

Competitors

 Today’s
change
Today’s
% change
SRPTSarepta Therapeutics...+0.96+5.49%
RGENRepligen Corp+0.62+2.64%
MACKMerrimack Pharmaceut...+0.25+3.75%
MGNXMacroGenics Inc+0.81+3.58%
Data as of 3:59pm ET, 05/24/2016

Financials

Next reporting dateSeptember 6, 2016
EPS forecast (this quarter)$0.62
Annual revenue (last year)$406.8M
Annual profit (last year)$149.9M
Net profit margin36.85%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chief Executive Officer &
Director
Arthur P. Bedrosian
President &
Chief Operating Officer
Michael J. Bogda
Corporate headquarters
Philadelphia, Pennsylvania

Forecasts